Seeing Is Believing

Currently out of the existing stock ratings of Jack Meehan, 35 are a BUY (53.03%), 15 are a HOLD (22.73%), 16 are a SELL (24.24%).
Analyst Jack Meehan, currently employed at BARCLAYS, carries an average stock price target met ratio of 98.04% that have a potential upside of 17.73% achieved within 260 days. Previously, Jack Meehan worked at STIFEL.
Jack Meehan’s has documented 157 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on LH, Laboratory of America Holdings at 01-Oct-2025.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$78
$4.01 (5.42%)
$70
9 days ago
(22-Oct-2025)
4/14 (28.57%)
$4.11 (5.56%)
55
Buy
$76
$2.01 (2.72%)
$78
10 days ago
(21-Oct-2025)
1/6 (16.67%)
$2.07 (2.80%)
160
Buy
$78
$4.01 (5.42%)
$70
10 days ago
(21-Oct-2025)
1/7 (14.29%)
$4.07 (5.51%)
171
Buy
$71
10 days ago
(21-Oct-2025)
4/10 (40%)
$16.84 (31.09%)
246
Hold
11 days ago
(20-Oct-2025)
14/25 (56%)
$18.28 (25.49%)
168
Which stock is Jack Meehan is most bullish on?
What Year was the first public recommendation made by Jack Meehan?